![Michael A. Byrne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael A. Byrne is Chief Financial Officer and Corporate Secretary of Viventia Biotech, Inc. Prior to joining Viventia, he was Chief Financial Officer of Hyal Pharmaceuticals, Inc. Mr. Byrne has over 20 years of executive experience in the biotech and pharmaceutical sector.
Postes actifs de Michael A. Byrne
| Sociétés | Poste | Début |
|---|---|---|
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Directeur Financier/CFO | 01/01/2000 |
Anciens postes connus de Michael A. Byrne
| Sociétés | Poste | Fin |
|---|---|---|
Hyal Pharmaceutical Corp.
 Hyal Pharmaceutical Corp. Pharmaceuticals: OtherHealth Technology Provides drug delivery solutions | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Health Technology |
Hyal Pharmaceutical Corp.
Hyal Pharmaceutical Corp. Pharmaceuticals: OtherHealth Technology Provides drug delivery solutions | Health Technology |
